Msaouel Pavlos, Lam Anthony P, Gundabolu Krishna, Chrysofakis Grigorios, Yu Yiting, Mantzaris Ioannis, Friedman Ellen, Verma Amit
Haematologica. 2014 May;99(5):930-6. doi: 10.3324/haematol.2013.101949. Epub 2014 Feb 7.
Even though alterations in platelet counts are presumed to be detrimental, their impact on the survival of patients has not been studied in large cohorts. The prevalence of thrombocytopenia and thrombocytosis was examined in a large inner city outpatient population of 36,262 individuals aged ≥65 years old. A significant association with shorter overall survival was found for both thrombocytopenia (HR=1.45; 95% CI: 1.36-1.56) and thrombocytosis (HR=1.75; 95% CI: 1.56-1.97) when compared to the survival of patients with normal platelet counts. This effect persisted across all ethnic groups. However, African-Americans (non-Hispanic Blacks) with either thrombocytopenia or thrombocytosis were at significantly lower risk compared to non-Hispanic Caucasians (HR=0.82; 95% CI: 0.69-0.96 and HR=0.70; 95% CI: 0.53-0.94, respectively). Furthermore, Hispanics with thrombocytosis were found to have a lower mortality risk compared to non-Hispanic Caucasians with thrombocytosis (HR=0.60; 95% CI: 0.44-0.81). A value of <125,000 platelets per microliter was a better prognostic marker for non-Hispanic Blacks and these subjects with this platelet count had similar overall survival to that of Caucasians with a value of <150,000 per microliter. In conclusion, thrombocytosis and thrombocytopenia are independently associated with shorter overall survival in elderly subjects and this effect is modified by ethnicity. Using different thresholds to define the association of thrombocytopenia and thrombocytosis with overall mortality risk among non-Hispanic Blacks may, therefore, be warranted.
尽管血小板计数的改变被认为是有害的,但在大型队列研究中尚未对其对患者生存的影响进行研究。在一个有36262名年龄≥65岁的市中心门诊人群中,对血小板减少症和血小板增多症的患病率进行了检查。与血小板计数正常的患者相比,血小板减少症(HR=1.45;95%CI:1.36-1.56)和血小板增多症(HR=1.75;95%CI:1.56-1.97)均与总体生存期缩短显著相关。这种影响在所有种族中都持续存在。然而,与非西班牙裔白种人相比,患有血小板减少症或血小板增多症的非裔美国人(非西班牙裔黑人)风险显著较低(HR分别为0.82;95%CI:0.69-0.96和HR=0.70;95%CI:0.53-0.94)。此外,与患有血小板增多症的非西班牙裔白种人相比,患有血小板增多症的西班牙裔患者死亡风险较低(HR=0.60;95%CI:0.44-0.81)。每微升血小板计数<125000对非西班牙裔黑人是一个更好的预后指标,这些血小板计数的受试者总体生存期与每微升<150000的白种人相似。总之,血小板增多症和血小板减少症与老年受试者总体生存期缩短独立相关,且这种影响因种族而异。因此,在非西班牙裔黑人中使用不同阈值来定义血小板减少症和血小板增多症与总体死亡风险的关联可能是有必要的。